These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32434838)

  • 1. HIV Is Associated with Modified Humoral Immune Responses in the Setting of HIV/TB Coinfection.
    van Woudenbergh E; Irvine EB; Davies L; de Kock M; Hanekom WA; Day CL; Fortune S; Alter G
    mSphere; 2020 May; 5(3):. PubMed ID: 32434838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-oxo-DHEA enhances impaired M. tuberculosis-specific T cell responses during HIV-TB coinfection.
    Vecchione MB; Laufer N; Sued O; Corti M; Salomon H; Quiroga MF
    J Biomed Sci; 2020 Jan; 27(1):20. PubMed ID: 31906962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection.
    Chukwuanukwu RC; Onyenekwe CC; Martinez-Pomares L; Flynn R; Singh S; Amilo GI; Agbakoba NR; Okoye JO
    Clin Exp Immunol; 2017 Feb; 187(2):259-268. PubMed ID: 27577087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model.
    Ganatra SR; Bucşan AN; Alvarez X; Kumar S; Chatterjee A; Quezada M; Fish A; Singh DK; Singh B; Sharan R; Lee TH; Shanmugasundaram U; Velu V; Khader SA; Mehra S; Rengarajan J; Kaushal D
    J Clin Invest; 2020 Oct; 130(10):5171-5179. PubMed ID: 32544085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection.
    Riou C; du Bruyn E; Stek C; Daroowala R; Goliath RT; Abrahams F; Said-Hartley Q; Allwood BW; Hsiao NY; Wilkinson KA; Arlehamn CSL; Sette A; Wasserman S; Wilkinson RJ;
    J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33945513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of
    Makatsa MS; Omondi FMA; Bunjun R; Wilkinson RJ; Riou C; Burgers WA
    J Immunol; 2022 Aug; 209(3):446-455. PubMed ID: 35777848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering lung granulomas in HIV & TB co-infection: unveiling macrophages aggregation with IL6R/STAT3 activation.
    Li Q; Wang C; Gou J; Kitanovski S; Tang X; Cai Y; Zhang C; Zhang X; Zhang Z; Qiu Y; Zhao F; Lu M; He Y; Wang J; Lu H
    Emerg Microbes Infect; 2024 Dec; 13(1):2366359. PubMed ID: 38855910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis.
    Nziza N; Cizmeci D; Davies L; Irvine EB; Jung W; Fenderson BA; de Kock M; Hanekom WA; Franken KLMC; Day CL; Ottenhoff THM; Alter G
    Front Immunol; 2022; 13():856906. PubMed ID: 35514994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of reactivation of latent tuberculosis infection due to SIV coinfection.
    Bucşan AN; Chatterjee A; Singh DK; Foreman TW; Lee TH; Threeton B; Kirkpatrick MG; Ahmed M; Golden N; Alvarez X; Hoxie JA; Mehra S; Rengarajan J; Khader SA; Kaushal D
    J Clin Invest; 2019 Dec; 129(12):5254-5260. PubMed ID: 31479428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosoma mansoni Infection Is Associated With a Higher Probability of Tuberculosis Disease in HIV-Infected Adults in Kenya.
    McLaughlin TA; Nizam A; Hayara FO; Ouma GS; Campbell A; Khayumbi J; Ongalo J; Ouma SG; Shah NS; Altman JD; Kaushal D; Rengarajan J; Ernst JD; Blumberg HM; Waller LA; Gandhi NR; Day CL; Benkeser D
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):157-163. PubMed ID: 33074856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody Subclass and Glycosylation Shift Following Effective TB Treatment.
    Grace PS; Dolatshahi S; Lu LL; Cain A; Palmieri F; Petrone L; Fortune SM; Ottenhoff THM; Lauffenburger DA; Goletti D; Joosten SA; Alter G
    Front Immunol; 2021; 12():679973. PubMed ID: 34290702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state.
    Duffy FJ; Thompson EG; Scriba TJ; Zak DE
    PLoS One; 2019; 14(7):e0219322. PubMed ID: 31306460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel humanized mouse model for HIV and tuberculosis co-infection studies.
    Bohórquez JA; Adduri S; Ansari D; John S; Florence J; Adejare O; Singh G; Konduru NV; Jagannath C; Yi G
    Front Immunol; 2024; 15():1395018. PubMed ID: 38799434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection.
    Spatola M; Nziza N; Irvine EB; Cizmeci D; Jung W; Van LH; Nhat LTH; Ha VTN; Phu NH; Nghia HDT; Thwaites G; Lauffenburger DA; Fortune S; Thuong NTT; Alter G
    Brain; 2024 Mar; ():. PubMed ID: 38442687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Immunoglobulin G on the Humoral Immunity in Patients with Tuberculosis/HIV Coinfection.
    Matsegora NA; Kaprosh AV; Vasylyeva TI; Antonenko PB; Antonenko K
    AIDS Res Hum Retroviruses; 2024 Apr; 40(4):246-252. PubMed ID: 38164121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anemia Burden, Types and Associated Risk Factors among Kenyan Human Immunodeficiency Virus-1 and
    Abonyo C; Shaviya N; Budambula V; Were T
    Ethiop J Health Sci; 2020 Sep; 30(5):661-670. PubMed ID: 33911826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of
    Strickland N; Müller TL; Berkowitz N; Goliath R; Carrington MN; Wilkinson RJ; Burgers WA; Riou C
    J Immunol; 2017 Aug; 199(7):2440-50. PubMed ID: 28794233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Functional Role for Antibodies in Tuberculosis.
    Lu LL; Chung AW; Rosebrock TR; Ghebremichael M; Yu WH; Grace PS; Schoen MK; Tafesse F; Martin C; Leung V; Mahan AE; Sips M; Kumar MP; Tedesco J; Robinson H; Tkachenko E; Draghi M; Freedberg KJ; Streeck H; Suscovich TJ; Lauffenburger DA; Restrepo BI; Day C; Fortune SM; Alter G
    Cell; 2016 Oct; 167(2):433-443.e14. PubMed ID: 27667685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma IL-33 levels and immune activation in HIV-TB coinfection: a cross-sectional study in Yaoundé, Cameroon.
    Essomba RG; Mbe RM; Ngogang MP; Ekono CB; Bitoungui VJN; Seni N; Nguwoh PS; Ateba PT; Kamdem SD; Nono JK; Ambomo MS; Assoumou MCO; Mbopi-Kéou FX
    Pan Afr Med J; 2023; 46():13. PubMed ID: 38035159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody glycosylation correlates with disease progression in SIV-
    Haycroft ER; Damelang T; Lopez E; Rodgers MA; Wines BD; Hogarth M; Ameel CL; Kent SJ; Scanga CA; O'Connor SL; Chung AW
    Clin Transl Immunology; 2023; 12(11):e1474. PubMed ID: 38020728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.